Cell membrane-specific self-assembly of peptide nanomedicine induces tumor immunogenic death to enhance cancer therapy
Pengsheng Fan, Yinghua Guan, Xiaoying Zhang, Jiaqi Wang, Yinsheng Xu, Benli Song, Suling Zhang, Hao Wang, Ya Liu, Zeng‐Ying Qiao
Abstract
T cells. We believe that PNpC can trigger ICD while killing cancer cells, providing a new reference for cancer immunotherapy.
Topics & Concepts
NanomedicinePeptideCancerCancer therapyCancer researchProgrammed cell deathCancer cellMembraneNanotechnologyMedicineMaterials scienceChemistryNanoparticleInternal medicineApoptosisBiochemistryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliverySupramolecular Self-Assembly in Materials